Daridorexant to Prevent Delirium After Heart Surgery
NCT06630390
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
POSTOPERATIVE DELIRIUM
POSTOPERATIVE COGNITIVE DECLINE
Interventions
DRUG:
Daridorexant 50 mg
OTHER:
Placebo
Sponsor
University of Rochester